| | | Index Performance | | Index | Sensex | Nifty | | Open | 13,018.21 | 3,788.85 | | High | 13,111.87 | 3,832.20 | | Low | 12,984.13 | 3,785.30 | | Today's Cls | 13,072.10 | 3,821.55 | | Prev Cls | 12,979.66 | 3,798.10 | | Change | 92.44 | 23.45 | | % Change | 0.71 | 0.62 | | | | Market Indicators | | Top Movers (Group A) | | Company | Price
(Rs) | %
chg | | Gainers | | Proctor & Gambler | 834.90 | 7.62 | | Chennai Petro | 188.90 | 6.09 | | Hexaware | 168.10 | 5.72 | | IndusInd Bank | 41.95 | 5.67 | | Orchid Chemicals | 261.85 | 5.14 | | Losers | | Reliance Petro | 71.50 | -3.51 | | Lanco Infra | 158.35 | -3.00 | | Ingersoll Rand | 277.75 | -2.94 | | IndoRama Synthetic | 50.70 | -2.87 | | BPCL | 302.25 | -2.83 | | | Market Statistics | | - | BSE | NSE | | Advances | 1,676 | 903 | | Declines | 864 | 435 | | Unchanged | 70 | 28 | | Volume(Nos) | 18.06cr | 34.41cr | | | | | | Market Commentary | | | Sensex gains amid volatility | | The market notched up gains for the second consecutive session on buying in pharma, fast moving consumer goods and metal stocks. | | The Sensex began the trading session above the 13000 mark at 13018, up 38 points, and moved up in early trades on buying in several heavyweights to touch an | | | | early high of 13070. However, the Sensex eased on profit booking in oil & metal stocks and touched an intra-day low of 12984. The market moved up on reports that the inflation was unchanged for the third week in a row at 6.46%. The Sensex surged and touched an intra-day high of 13112 on substantial buying in pharma, fast moving consumer goods, metal and auto stocks. The Sensex settled at 13072, up 92 points. The Nifty ended the session at 3822, up 23 points. | | | Movers & Shakers | - Amtek Auto closed in the red despite signing a 50:50 joint venture pact with VCST Industrial Products of Belgium to manufacture powertrain components.
- Shringar Cinemas gained on reports that the company has acquired a 3-screen operational multiplex at Anand, Gujarat.
- Patel Engineering moved up on bagging an order worth Rs806 crore in a joint venture with Gammon Ltd.
| | | |
The breadth of the market was positive. Of the 2,610 stocks traded on the BSE, 1,676 stocks advanced, 864 stocks declined and 70 stocks ended unchanged. Among the sectoral indices the BSE HC Index advanced 1.89% at 3649 followed by the BSE Metal Index (up 1.71% at 8488), the BSE FMCG Index (up 1.57% at 1739) and the BSE Auto Index (up 1.36% at 4869).
Most of the heavyweights ended in positive territory. Dr Reddy's rose 3.13% at Rs728, NTPC advanced 3.06% at Rs150, ITC climbed 2.49% at Rs150, Ranbaxy surged 2.13% at Rs353, Gujarat Ambuja gained 2.01% at Rs107, Tata Steel added 1.88% at Rs450, Satyam Computers jumped 1.86% at Rs470, Grasim advanced 1.78% at Rs2,091, Tata Motors added 1.77% at Rs728 and HDFC Bank was up 1.75% at Rs949. Among the laggards Wipro shed 1.27% at Rs558 and TCS slipped 1.27% at Rs1,231. HDFC, BHEL, ICICI Bank, Cipla and ACC ended with marginal losses.
Pharma stocks were in the limelight. Lupin soared 4.82% at Rs606, Aurobindo Pharma advanced 4.68% at Rs679, Sun Pharma added 4.08% at Rs1,059 and Matrix Labs gained 3.36% at Rs175. Biocon, Cadila, Wockhardt and Glaxo gained 2-3% each.
Over 32.16 lakh Idea Cellular shares changed hands on the BSE followed by Reliance Petro (23.53 lakh shares), SAIL (20.27 lakh shares), HLL (19 lakh shares) and ITC (17.64 lakh shares).
Value-wise Reliance Industries registered a turnover of Rs77 crore on the BSE followed by ICICI Bank (Rs50 crore), Tata Steel (Rs49 crore), Bajaj Auto (Rs46 crore) and Infosys (Rs43 crore).
| | | | | | | | European Indices at 15:30 IST on 30-03-2007 | | | | Index | Level | Change (pts) | Change (%) | | FTSE 100 | 6304.70 | -19.50 | -0.31 | | CAC 40 Index | 5618.76 | -12.77 | -0.23 | | DAX Index | 6899.92 | 2.84 | 0.04 | | | | | | | | | | | Asian Indices at close on 30-03-2007 | | | | Index | Level | Change (pts) | Change (%) | | Nikkei 225 | 17287.65 | 23.71 | 0.14 | | Hang Seng Index | 19800.93 | -20.85 | -0.11 | | Kospi Index | 1452.55 | 1.60 | 0.11 | | Straits Times Index | 3231.24 | 2.36 | 0.07 | | Jakarta Composite Index | 1830.92 | 13.21 | 0.73 | | | | | | | | | | | | “This document has been prepared by Sharekhan Ltd. This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction.
Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is from publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees (“SHAREKHAN and affiliates”) are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. We do not represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.
SHAREKHAN & affiliates may have used the information set forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. Any comments or statements made herein are those of the analyst and do not necessarily reflect those of SHAREKHAN.” | To unsubscribe write to myaccount@sharekhan.com
| |
